根治性顺行模块化胰脾切除术:神话还是现实?系统评价与试验序贯Meta分析
该系统评价与试验序贯Meta分析比较根治性顺行模块化胰脾切除术(RAMPS)与标准远端胰腺切除术,纳入比较研究。结果显示两组总生存相似(HR 1.33,95%CI 0.89-2.00),无病生存、R0切除率、主要并发症与死亡率等均相似,仅RAMPS住院时间更短(-3.48天;-6.66至-0.31天)。结论认为RAMPS并未在肿瘤学结局上显示优越性,数据稳健,无需进一步回顾性比较研究。
要点
- RAMPS与标准远端胰腺切除术的总生存和无病生存相似。
- R0切除率、主要并发症、死亡率及术后胰瘘等均无显著差异。
- RAMPS住院时间更短,但该终点所需样本量未达到,假阳性不能排除。
核心结论
- RAMPS在保证更好的总生存和无病生存方面并不优于标准远端胰腺切除术。
- 数据稳健,进一步回顾性比较研究已无必要。
研究设计与样本
- 系统评价与试验序贯Meta分析,纳入所有比较RAMPS与标准远端胰腺切除术的研究。
- 采用随机效应分析,计算风险比、比值比和均数差,并用试验序贯分析评估I型和II型错误。
主要发现
- 主要终点总生存: accrued样本量1172,所需样本量176,HR 1.33(95%CI 0.89-2.00),两组相似。
- 无病生存、R0切除率、主要并发症与死亡率、临床相关术后胰瘘、胃排空延迟、胰腺切除术后出血和手术时间均相似,且达到所需样本量,可排除假等效。
- 住院时间RAMPS更短(-3.48天;-6.66至-0.31天),但 accrued样本量826,所需样本量未达到,假阳性不能排除。
关键数值与推荐
- 主要终点总生存HR 1.33(95%CI 0.89-2.00),所需样本量176, accrued样本量1172。
- 住院时间均数差-3.48天(95%CI -6.66至-0.31天), accrued样本量826,所需样本量未达到。
临床怎么用
- 在肿瘤学结局上,RAMPS不应被常规推荐优于标准远端胰腺切除术。
- RAMPS可能缩短住院时间,但该证据存在假阳性风险,需谨慎解读。
局限性
- 住院时间终点的 accrued样本量未达到所需样本量,假阳性结果不能排除。
- 纳入研究均为比较性研究,非随机对照试验。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: The superiority of radical antegrade modular pancreatosplenectomy versus standard distal pancreatectomy has never been demonstrated. METHODS: A systematic review was performed to identify all comparative studies about radical antegrade modular pancreatosplenectomy versus standard distal pancreatectomy. Random-effects analysis was performed, and hazard ratios, odds ratios, and mean differences were calculated. Using trial sequential analysis, type I and II errors were evaluated by comparing the accrued sample size with the required sample size. When the required sample size is superior to the accrued sample size, type I or II errors can be hypothesized. The critical endpoint was overall survival. Secondary endpoints were disease-free survival, R0 resection rate, major morbidity and mortality rate, clinically relevant postoperative pancreatic fistula, delayed gastric emptying, postpancreatectomy hemorrhage, length of stay, and operative time. RESULTS: The accrued sample size and required sample size were 1,172 and 176 for the primary endpoint, respectively. The overall survival was similar between the 2 groups, with a hazard ratio of 1.33 (95% confidence interval: 0.89-2.00). The required sample size reached, and false-negative equivalence can be excluded. Disease-free survival, R0 resection rate, major morbidity and mortality rate, clinically relevant postoperative pancreatic fistula, delayed gastric emptying, postpancreatectomy hemorrhage, and operative time are similar and reached required sample sizes, suggesting that false equivalence can be excluded. Length of stay was shorter in radical antegrade modular pancreatosplenectomy than in standard distal pancreatectomy (-3.48 days; -6.66 to -0.31 days). The accrued sample size was 826, and the required sample size was not reached. False-positive results cannot be excluded. CONCLUSION: Radical antegrade modular pancreatosplenectomy was not superior in guaranteeing a better overall survival and disease-free survival. The data are robust, and further retrospective comparative studies are unnecessary.
引用
- Ricci C, D'Ambra V, Alberici L, et al. Radical antegrade modular pancreatosplenectomy: Myth or reality? A systematic review and trial sequential meta-analysis. Surgery. 2025. PMID: 40049021. doi:10.1016/j.surg.2025.109278
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。